Abstract
The synthesis of a series of long-chain formoterol analogues in which the terminal ether residue of the beta-phenethyl-amino-substituent has been extended beyond the methyl ether residue present in the parent compound are described. Evaluation of these analogues as beta(2)-adrenoceptor agonists was used to provide an insight into the factors controlling the magnitude and duration of receptor activation.
MeSH terms
-
Adrenergic beta-2 Receptor Agonists*
-
Adrenergic beta-Agonists / chemical synthesis
-
Adrenergic beta-Agonists / chemistry*
-
Adrenergic beta-Agonists / pharmacology
-
Albuterol / analogs & derivatives*
-
Albuterol / chemistry
-
Animals
-
Ethanolamines / chemical synthesis
-
Ethanolamines / chemistry*
-
Ethanolamines / pharmacology
-
Formoterol Fumarate
-
Guinea Pigs
-
Humans
-
In Vitro Techniques
-
Muscle Contraction / drug effects
-
Muscle, Smooth / drug effects
-
Muscle, Smooth / physiology
-
Salmeterol Xinafoate
-
Stereoisomerism
-
Structure-Activity Relationship
-
Time Factors
Substances
-
Adrenergic beta-2 Receptor Agonists
-
Adrenergic beta-Agonists
-
Ethanolamines
-
Salmeterol Xinafoate
-
Albuterol
-
Formoterol Fumarate